ID: ALA5278983
Max Phase: Preclinical
Molecular Formula: C29H23N5O2
Molecular Weight: 473.54
Associated Items:
ID: ALA5278983
Max Phase: Preclinical
Molecular Formula: C29H23N5O2
Molecular Weight: 473.54
Associated Items:
Canonical SMILES: CCc1cc(-c2nc3ccccc3c(=O)[nH]2)cc2c1OC(N)=C(C#N)C2c1c(C)[nH]c2ccccc12
Standard InChI: InChI=1S/C29H23N5O2/c1-3-16-12-17(28-33-23-11-7-5-9-19(23)29(35)34-28)13-20-25(21(14-30)27(31)36-26(16)20)24-15(2)32-22-10-6-4-8-18(22)24/h4-13,25,32H,3,31H2,1-2H3,(H,33,34,35)
Standard InChI Key: BCVUSTSRWNAOBO-UHFFFAOYSA-N
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 473.54 | Molecular Weight (Monoisotopic): 473.1852 | AlogP: 5.16 | #Rotatable Bonds: 3 |
Polar Surface Area: 120.58 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.94 | CX Basic pKa: 4.11 | CX LogP: 4.94 | CX LogD: 4.85 |
Aromatic Rings: 5 | Heavy Atoms: 36 | QED Weighted: 0.33 | Np Likeness Score: -0.78 |
1. Sardar A, Ansari A, Gupta S, Sinha S, Pandey S, Rai D, Kumar M, Bhatta RS, Trivedi R, Sashidhara KV.. (2022) Design, synthesis and biological evaluation of new quinazolinone-benzopyran-indole hybrid compounds promoting osteogenesis through BMP2 upregulation., 244 [PMID:36219902] [10.1016/j.ejmech.2022.114813] |
Source(1):